Vigil Neuroscience Return On Asset vs. Shares Owned By Institutions

VIGL Stock  USD 2.47  0.17  7.39%   
Based on the measurements of profitability obtained from Vigil Neuroscience's financial statements, Vigil Neuroscience may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Vigil Neuroscience's ability to earn profits and add value for shareholders. At this time, Vigil Neuroscience's Debt To Equity is quite stable compared to the past year. Graham Net Net is expected to rise to 2.56 this year, although the value of Operating Cash Flow Per Share will most likely fall to (1.91).
For Vigil Neuroscience profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vigil Neuroscience to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vigil Neuroscience utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vigil Neuroscience's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vigil Neuroscience over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.07)
Return On Assets
(0.40)
Return On Equity
(0.70)
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vigil Neuroscience Shares Owned By Institutions vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vigil Neuroscience's current stock value. Our valuation model uses many indicators to compare Vigil Neuroscience value to that of its competitors to determine the firm's financial worth.
Vigil Neuroscience is rated third in return on asset category among its peers. It is rated first in shares owned by institutions category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Vigil Neuroscience by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Vigil Shares Owned By Institutions vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Vigil Neuroscience

Return On Asset

 = 

Net Income

Total Assets

 = 
-0.4
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Vigil Neuroscience

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
80.15 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.

Vigil Shares Owned By Institutions Comparison

Vigil Neuroscience is currently under evaluation in shares owned by institutions category among its peers.

Vigil Neuroscience Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vigil Neuroscience, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vigil Neuroscience will eventually generate negative long term returns. The profitability progress is the general direction of Vigil Neuroscience's change in net profit over the period of time. It can combine multiple indicators of Vigil Neuroscience, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-5 K-4.8 K
Operating Income-88.9 M-84.4 M
Income Before Tax-82.6 M-86.8 M
Total Other Income Expense Net6.2 M6.5 M
Net Loss-61.5 M-64.5 M
Net Loss-82.6 M-86.8 M
Income Tax Expense-521.1 K-495 K
Net Interest IncomeM5.2 M
Interest IncomeM5.2 M
Net Loss-78.9 M-82.9 M
Non Operating Income Net Other521.1 K463.2 K
Change To Netincome4.9 M4.7 M
Net Loss(2.13)(2.24)
Income Quality 0.85  0.58 
Net Income Per E B T 1.14  1.10 

Vigil Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vigil Neuroscience. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vigil Neuroscience position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vigil Neuroscience's important profitability drivers and their relationship over time.

Use Vigil Neuroscience in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vigil Neuroscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vigil Neuroscience will appreciate offsetting losses from the drop in the long position's value.

Vigil Neuroscience Pair Trading

Vigil Neuroscience Pair Trading Analysis

The ability to find closely correlated positions to Vigil Neuroscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vigil Neuroscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vigil Neuroscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vigil Neuroscience to buy it.
The correlation of Vigil Neuroscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vigil Neuroscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vigil Neuroscience moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vigil Neuroscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Vigil Neuroscience position

In addition to having Vigil Neuroscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Raw Materials Thematic Idea Now

Raw Materials
Raw Materials Theme
Companies that are involved with the development and processing of raw materials such as silver or forestry. The Raw Materials theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Raw Materials Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports:
Check out World Market Map.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
To fully project Vigil Neuroscience's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vigil Neuroscience at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vigil Neuroscience's income statement, its balance sheet, and the statement of cash flows.
Potential Vigil Neuroscience investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vigil Neuroscience investors may work on each financial statement separately, they are all related. The changes in Vigil Neuroscience's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vigil Neuroscience's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.